162576-01-4

Basic information

• Product Name: N-Cbz-N-MethylethylenediaMine HCl
• Synonyms: N-Cbz-N-MethylethylenediaMine HCl;1-CBZ-1-Methyl-ethylenediaMine-HCl
• CAS NO: 162576-01-4
• Molecular Formula: C₁₁H₁₆N₂O₂*ClH
• Molecular Weight: 244.71788
• Mol File: 162576-01-4.mol

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: N-Cbz-N-MethylethylenediaMine HCl(CAS DataBase Reference)
• NIST Chemistry Reference: N-Cbz-N-MethylethylenediaMine HCl(162576-01-4)
• EPA Substance Registry System: N-Cbz-N-MethylethylenediaMine HCl(162576-01-4)

Safety Data

• Hazardous Substances Data: 162576-01-4(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
N-Cbz-N-Methylethylenediamine HCl is used as a reagent for introducing amine groups into molecules, facilitating the synthesis of a wide range of organic compounds.
Used in Peptide Chemistry:
In peptide chemistry, Boc-MEDA is utilized for the preparation of peptide and protein derivatives, contributing to the development of complex peptide structures.
Used in Pharmaceutical Compound Synthesis:
Boc-MEDA serves as a building block in the synthesis of various pharmaceutical compounds, playing a crucial role in the creation of new drugs and medicinal agents.
Used in Chemical Intermediates Production:
N-Cbz-N-MethylethylenediaMine HCl is also used in the production of chemical intermediates, which are essential precursors in the synthesis of a multitude of chemical products.
Used in Research and Development:
In the research and development sector, Boc-MEDA is employed for exploring new synthetic pathways and for the discovery of novel chemical entities with potential applications in various industries.

InChI:InChI=1S/C11H16N2O2.ClH/c1-13(8-7-12)11(14)15-9-10-5-3-2-4-6-10;/h2-6H,7-9,12H2,1H3;1H

Upstream product

• 1221593-52-7 methyl-[2-(2,2,2-trifluoro-acetylamino)-ethyl]carbamic acid benzyl ester 

Downstream Products

• 1048360-18-4 {2-[boc-Arg(Pbf)]-aminoethyl}methylcarbamic acid benzyl ester 
• 1221593-54-9 {(S)-1-[2-(benzyloxycarbonyl-methyl-amino)-ethylcarbamoyl]-5-tert-butoxycarbonylamino-pentyl}-carbamic acid 9H-fluoren-9-ylmethyl ester 
• 1276122-67-8 {2-[2-tert-butylmalonyl-Arg(Pbf)]aminoethyl}methylcarbamic acid benzyl ester 
• 1221593-56-1 {(S)-5-acetylamino-5-[2-(benzyloxycarbonyl-methyl-amino)-ethyl carbamoyl]-pentyl}-carbamic acid isopropyl ester 
• 1221593-55-0 {(S)-5-amino-5-[2-(benzyloxycarbonyl-methyl-amino)-ethylcarbamoyl]-pentyl}-carbamic acid tert-butyl ester 

Relevant articles and documents

METHODS AND COMPOSITIONS RELATING TO GENOTOXIN COLIBACTIN

The technology described herein is directed to compounds which are substrates for ClbP, acting as fluorescent probes for ClbP activity. Further provided herein are methods for measuring ClbP activity, screening for ClbP inhibitors, detecting colibactin, a

COMPOSITIONS COMPRISING ENZYME-CLEAVABLE PRODRUGS OF ACTIVE AGENTS AND INHIBITORS THEREOF

The present disclosure provides pharmaceutical compositions, and their methods of use, where the pharmaceutical compositions comprise a prodrug that provides enzymatically-controlled release of a drug and an enzyme inhibitor that interacts with the enzyme(s) that mediates the enzymatically-controlled release of the drug from the prodrug so as to attenuate enzymatic cleavage of the prodrug. The disclosure provides pharmaceutical compositions which comprise an enzyme inhibitor and a prodrug that contains an enzyme-cleavable moiety that, when cleaved, facilitates release of the drug.

COMPOSITIONS COMPRISING ENZYME-CLEAVABLE OPIOID PRODRUGS AND INHIBITORS THEREOF

Pharmaceutical compositions and their methods of use are provided, where the pharmaceutical compositions comprise an opioid prodrug that provides enzymatically-controlled release of an opioid, and an enzyme inhibitor that interacts with the enzyme(s) that mediates the enzymatically-controlled release of the opioid from the opioid prodrug so as to attenuate enzymatic cleavage of the opioid prodrug.